Episode 47 - Marc Lajoie, CEO at Outpace Bio
Update: 2024-12-31
Description
"If you bring powerful technology to a problem that is well understood, then you can really make a difference." - Marc Lajoie, CEO at Outpace Bio
Welcome to the latest episode of Biorasi's Few & Far Between podcast. Join host Chris O'Brien and guest, Marc Lajoie, as they discuss how de novo proteins can be used to reprogram immune cells.
Tune in today!
Comments
In Channel